« Back to Record
De Cock, E., Hutton, J., Canney, P., Body, J.-J., Barrett-Lee, P., Neary, M., & Lewis, G. (2005). Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy. Supportive care in cancer, 13(12), 975-986. doi:10.1007/s00520-005-0828-1
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/83381



